Boston Scientific 2Q Sales Recover
27 July 2021 - 9:15PM
Dow Jones News
By Matt Grossman
Boston Scientific Corp. on Tuesday returned to a profit in the
second quarter, as sales recovered amid higher healthcare demand as
the coronavirus pandemic eased.
The Marlborough, Mass.-based medical-devices maker logged
earnings of 12 cents a share, compared with a loss of 11 cents a
share a year earlier. Total net income was $186 million, compared
with a net loss of $147 million.
Stripping out one-time items, the company's adjusted earnings
were 40 cents a share. Analysts polled by FactSet were forecasting
adjusted earnings of 37 cents a share.
Sales rose to $3.08 billion from $2 billion a year earlier, the
company said. Analysts had been anticipating sales of $2.94
billion.
Medical-surgical sales rose 65% to $948 million. Rhythm and
neuro sales were up 65% at $866 million. Cardiovascular sales
improved by 51% to $1.26 billion, the company said.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
July 27, 2021 07:02 ET (11:02 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Apr 2024 to May 2024
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From May 2023 to May 2024